Adam Mizeracki
- Surgery top 2%
- Oncology top 5%
- Molecular Biology
- Neurology top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Paula E. NorthMilton WanerMartín C. MihmRobert E. MrakRobin A.J. NicholasJay KincannonJ. Y. SuenCharles A. James
- Topics
- Vascular Tumors and Angiosarcomas (5 papers)Vascular Malformations and Hemangiomas (5 papers)Cardiac Arrest and Resuscitation (2 papers)
- Journals
- Molecular and Cellular BiologyBiochemical and Biophysical Research CommunicationsJournal of the American Academy of Dermatology
- Partner nations
- United StatesSwedenSwitzerland
In The Last Decade
Adam Mizeracki
12 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Surgery 1.1k
- Oncology 635
- Molecular Biology 568
- Neurology 451
- Pathology and Forensic Medicine 389
Countries citing papers authored by Adam Mizeracki
This map shows the geographic impact of Adam Mizeracki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Mizeracki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Mizeracki more than expected).
Fields of papers citing papers by Adam Mizeracki
This network shows the impact of papers produced by Adam Mizeracki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Mizeracki. The network helps show where Adam Mizeracki may publish in the future.
Co-authorship network of co-authors of Adam Mizeracki
This figure shows the co-authorship network connecting the top 25 collaborators of Adam Mizeracki. A scholar is included among the top collaborators of Adam Mizeracki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Mizeracki. Adam Mizeracki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 14 | |
| 3 | 7 | |
| 4 | 23 | |
| 5 | 14 | |
| 6 | 453 | |
| 7 | 39 | |
| 8 | GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. | 20 |
| 9 | 145 | |
| 10 | 206 | |
| 11 | A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. | 311 |
| 12 | GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomasbreakdown → | 557 |
About Adam Mizeracki
Adam Mizeracki is a scholar working on Oncology, Emergency Medicine and Immunology and Allergy, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Vascular Tumors and Angiosarcomas (5 papers), Vascular Malformations and Hemangiomas (5 papers) and Cardiac Arrest and Resuscitation (2 papers). The work is most often cited by research in Neurology (451 citations), Surgery (1.1k citations) and Oncology (635 citations). Adam Mizeracki has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include Paula E. North, Milton Waner, Martín C. Mihm, Robert E. Mrak, Robin A.J. Nicholas, Jay Kincannon, J. Y. Suen, Charles A. James, Ilona J. Frieden and Na Li. Their work appears in journals such as Molecular and Cellular Biology, Biochemical and Biophysical Research Communications and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.